NCT02175966View on ClinicalTrials.gov

Short Duration Combination Therapy With Daclatasvir, Asunaprevir, BMS-791325 and Sofosbuvir in Subjects Infected With Chronic Hepatitis-C (FOURward Study)

PHASE2CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

July 28, 2014

Primary Completion Date

January 28, 2015

Study Completion Date

December 17, 2015

Conditions
Hepatitis C
Interventions
DRUG

DCV/ASV/BMS-791325

DRUG

Ribavirin

DRUG

Sofosbuvir

DRUG

Peginterferon α-2a

Trial Locations (7)

21093

Johns Hopkins University, Lutherville

46202

Indiana University Health - University Hospital, Indianapolis

Indiana University Med Center, Indianapolis

60611

Northwestern Memorial Hospital, Chicago

Northwestern University Feinberg School Of Medicine, Chicago

78215

Texas Liver Institute, San Antonio

92377

Inland Empire Liver Foundation, Rialto

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY